Verification Opinions and Public Disclosure of the List of Incentive Objects for the 2026 Restricted Stock Incentive Plan
Shandong Linuo Pharmaceutical Packaging Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of the 4th Board of Directors on February 26, 2026, where it reviewed and approved the proposal regarding the "2026 Restricted Stock Incentive Plan (Draft)" and its summary. For detailed content, please refer to the announcement disclosed by the Company on February 27, 2026, on the Giant Tide Information Network (http://www.cninfo.com.cn).
According to the "Administrative Measures for Equity Incentives of Listed Companies" (hereinafter referred to as "the Measures"), the "Listing Rules for the Growth Enterprise Market of the Shenzhen Stock Exchange" (hereinafter referred to as "the Listing Rules"), the "Self-Regulatory Guidelines No. 1 for Listed Companies on the Growth Enterprise Market of the Shenzhen Stock Exchange" (hereinafter referred to as "Self-Regulatory Guidelines No. 1"), and the Company's Articles of Association, the Company has publicly disclosed the list of individuals proposed for the initial grant under the 2026 Restricted Stock Incentive Plan (hereinafter referred to as "this Incentive Plan") internally.
The Board's Remuneration and Assessment Committee has verified the list of individuals proposed for the initial grant based on the public disclosure situation. The relevant public disclosure and verification situation are as follows: